ANIX News and Press, Anixa Biosciences Inc. From 08/23/21

Anixa Biosciences Congratulates Director, Dr. Arnold Baskies for His Appointment to the WHO's Global Breast Cancer Initiative PR Newswire SAN JOSE, Calif. , Aug. 23, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused ...

Anixa Biosciences Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine Technology Technology Invented and Developed at Cleveland Clinic PR Newswire SAN JOSE, Calif. , Aug. 18, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechn...

Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Cleveland Clinic PR Newswire SAN JOSE, Calif. , May 26, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused...

Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from US FDA for CAR-T IND Application PR Newswire SAN JOSE, Calif. , May 20, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the...

German Life Science IT company OntoChem GmbH has assigned its drug discovery technologies and assets, including its drug discovery collaboration with Anixa Biosciences (ANIX),  to newly formed MolGenie GmbH.Anixa and OntoChem were seeking to develop an orally administrable, metabolically...

OntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie PR Newswire HALLE (SAALE) , Germany , May 7, 2021 /PRNewswire/ -- OntoChem GmbH, a German Life Science IT company, announced today that it has assigned its drug discovery technologies and...

Gainers: Chemomab Therapeutics (CMMB) +27%, Obalon Therapeutics (OBLN) +18%, Galectin Therapeutics (GALT) +13%, Sundial Growers (SNDL) +9%, Clover Health Investments (CLOV) +6%.Losers: Haemonetics (HAE) -31%, LifeMD (LFMD) -15%, 180 ...

Anixa Biosciences (ANIX) announces that the study testing its Chimeric Antigen Receptor-T cell therapy ((CAR-T)) being developed in partnership with Moffitt Cancer Center ((MCC)) is being placed on hold following an additional information request by the U.S. FDA.Within the next 30 days, ...

Anixa Biosciences and Moffitt Cancer Center Report US FDA Request of Additional Information for CAR-T Therapy PR Newswire SAN JOSE, Calif. , April 19, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatmen...

Piper Sandler paints an upbeat outlook for the synthetic biology (SynBio) space as the firm initiates coverage on Codexis (CDXS) and Twist Biosciences (TWST).Twist Bioscience and Codexis in focus as Piper Sandler sizes up synthetic biologyThe analyst Steven Mah predict the global market for s...